ロード中...
Seatbelts in CAR therapy: How Safe Are CARS?
T-cells genetically redirected with a chimeric antigen receptor (CAR) to recognize tumor antigens and kill tumor cells have been infused in several phase 1 clinical trials with success. Due to safety concerns related to on-target/off-tumor effects or cytokine release syndrome, however, strategies to...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2015-05-01
|
| シリーズ: | Pharmaceuticals |
| 主題: | |
| オンライン･アクセス: | http://www.mdpi.com/1424-8247/8/2/230 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|